Vision changes before the pain arrives. That defines migraine with aura for most people who have it: a 20-to-60-minute warning of zigzag lines, flashing lights, blind spots, or other neurological symptoms before the headache. Aura is the brain signaling that an attack is starting, and recognizing it gives some people a window to take acute medication early or find a quiet space.
Migraine with aura is its own diagnostic category in the International Classification of Headache Disorders, with criteria that distinguish it from migraine without aura, from stroke or TIA, and from other neurological conditions. The diagnostic framework matters because the treatment and risk profile for migraine with aura differ from migraine without aura, particularly around hormonal contraception and stroke risk2.
This article covers what aura is, the types of aura, how it differs from the headache phase, the prevalence and clinical context, the stroke-risk consideration, and the signs that warrant prompt evaluation.
This article is for educational purposes only and does not replace evaluation or treatment by a qualified clinician. Migraine with aura has specific treatment considerations including stroke risk; consult a neurologist for personalized care. Last updated: May 30 2026 | By Austin Murphy
Key Takeaways
- Aura is a transient neurological symptom complex that precedes or accompanies migraine, lasting 5-60 minutes per ICHD-3 criteria1
- A minority of people with migraine experience aura at least sometimes; most have migraine without aura
- Migraine with aura is associated with modestly elevated ischemic stroke risk, particularly in women who smoke or use combined hormonal contraceptives2
- Sudden severe headache (worst of life), aura lasting more than 60 minutes, motor weakness, or first-ever aura after age 50 warrants urgent neurological evaluation to rule out stroke or other conditions
What Aura Actually Is
Aura is a wave of neurological dysfunction that moves across the cerebral cortex during a migraine attack. Current research describes the underlying phenomenon as cortical spreading depression: a slow wave of electrical activity (and then suppression) that travels across the surface of the brain at roughly 3-5 millimeters per minute1. The symptoms a person experiences depend on which part of the brain the wave is moving through at any given moment.
Most often, the wave starts in the visual cortex at the back of the brain. That’s why visual aura is by far the most common type. As the wave moves forward, it can produce sensory symptoms (tingling or numbness), then language symptoms (difficulty finding words or producing speech), and, in rare cases, motor symptoms (weakness on one side of the body). The 5-to-60 minute duration of aura corresponds to the time the wave takes to move across affected cortical regions.
Aura ends as the cortical spreading depression dissipates1. A subsequent headache phase is driven by a different mechanism (trigeminovascular activation and CGRP release), though aura and headache are connected: the cortical spreading depression appears to trigger the headache phase by activating pain pathways in the meninges.
Recognizing the Types of Aura
ICHD-3 diagnostic criteria recognize five types of aura symptoms, each tied to a specific brain region1.
Visual aura (the most common type)
Common patterns include zigzag lines (fortification spectra), shimmering or sparkling areas, blind spots (scotoma) that may grow over minutes, blurry patches, flashing lights, geometric patterns, or temporary partial vision loss. The visual disturbance is usually in both eyes (cortical origin), not one. It typically starts as a small spot near the center of vision and expands outward, often with a shimmering edge, before fading within the standard ICHD-3 aura duration range1.
Sensory aura
Tingling, numbness, or pins-and-needles sensation that typically starts in the hand and spreads up the arm, into the face (often around the lips), and sometimes to the leg or trunk. The progression follows the body’s representation in the sensory cortex, so the pattern is relatively predictable. Sensations move rather than appearing all at once, which helps distinguish it from sudden numbness that might suggest stroke.
Speech aura
Difficulty finding words (anomia), trouble producing speech (aphasia), garbled speech, or trouble understanding spoken language. The person may know what they want to say but be unable to form the words, or may speak fluently but say the wrong words. Resolves within the standard ICHD-3 aura duration1.
Motor aura (rare; defines hemiplegic migraine)
Weakness on one side of the body during the aura. When motor weakness is part of the aura, the diagnosis is hemiplegic migraine, a distinct subtype with separate diagnostic criteria. Hemiplegic migraine is uncommon but important to recognize because the motor weakness can mimic stroke and may require specialized neurologic care.
Brainstem aura (rare; previously called basilar migraine)
Symptoms suggest brainstem involvement: vertigo, double vision, slurred speech (dysarthria, distinct from speech aura), ringing in the ears, decreased consciousness, ataxia. The diagnosis requires two or more of these symptoms occurring together as the aura.
How Aura Differs From the Headache Phase
The aura phase and the headache phase are different experiences with different underlying mechanisms. Most people learn to distinguish them through repeated attacks.
Aura is neurological without pain (in most cases). The visual zigzags, tingling, or speech difficulty come without headache pain, and the aura is often the warning that headache pain will follow. Aura typically lasts 5-60 minutes per ICHD-3 criteria1, with most attacks lasting closer to the lower end of that range.
The headache phase follows aura within 60 minutes in the typical pattern. Headache features are the standard migraine pattern: usually one-sided, pulsating, moderate-to-severe in intensity, worsened by physical activity, often with nausea and light/sound sensitivity. Without treatment, the headache phase lasts 4-72 hours per ICHD-3 criteria.
Some people experience aura without subsequent headache (sometimes called “silent migraine” or “acephalgic migraine”). This pattern is more common in older adults, particularly those who had migraine with aura when younger and now experience just the aura without the pain.
Prevalence and Demographics
Migraine in general affects approximately 12% of US adults, with women affected approximately three times more often than men3. Of people with migraine, a minority experience aura at least sometimes. The remainder have migraine without aura.
Aura is more common in younger adults and tends to become less prominent or absent in some people as they age past 50, though new-onset aura after 50 should always be evaluated to rule out other causes. A subset of migraineurs experience both types: most attacks have aura, but some don’t, or vice versa.
Family history matters. Migraine with aura clusters in families more strongly than migraine without aura, suggesting genetic factors. Specific genetic conditions (familial hemiplegic migraine, CADASIL) involve genes related to ion channel function and cause distinct migraine-with-aura syndromes. For the broader picture of how migraine is distinguished from other headache types, see our migraine vs headache guide.
The Stroke Risk Consideration
One of the most important clinical differences between migraine with aura and migraine without aura is stroke risk. Multiple large studies have shown that migraine with aura is associated with approximately 2x the relative risk of ischemic stroke compared to people without migraine2. Migraine without aura is not associated with elevated stroke risk in most analyses.
The absolute risk numbers matter for context. A young woman in her 30s with migraine with aura has roughly twice the stroke risk of a peer without migraine, but the baseline risk is so low that the doubled risk is still small in absolute terms. The clinical importance is in how that elevated risk interacts with other risk factors.
Specific risk-multiplying combinations:
- Aura plus smoking plus combined oral contraceptives: stroke risk multiplies meaningfully. Most guidelines recommend against combined hormonal contraceptives in women with migraine with aura.
- Aura plus smoking alone: still elevated risk above either factor alone.
- Aura plus age 55+: baseline stroke risk rises with age regardless, so the combination becomes more clinically significant.
- Aura plus uncontrolled hypertension: compounds vascular risk.
Practical implications: women with migraine with aura should discuss contraceptive options carefully with their clinicians; progestin-only methods are generally preferred. Smoking cessation has outsized benefit. Blood pressure management matters more.
How Aura Is Diagnosed
ICHD-3 diagnostic criteria for migraine with aura require1:
- At least 2 attacks fulfilling the criteria
- One or more fully reversible aura symptoms (visual, sensory, speech, motor, brainstem, or retinal)
- At least 3 of the following 6 characteristics: gradual development of aura symptoms (≥5 minutes), 2+ aura symptoms in succession, each individual aura lasts 5-60 minutes, at least one symptom is unilateral, at least one symptom is positive (zigzags, tingling, not just loss), aura is accompanied or followed within 60 minutes by headache1
The criteria are deliberately detailed because aura can mimic stroke or TIA. A neurologist evaluating new-onset aura considers: stroke (sudden onset, unilateral weakness or numbness, often without prior headache pattern), TIA (similar to stroke but resolves), seizure (with specific seizure features), other neurological conditions. The “gradual development” criterion is particularly important because stroke symptoms typically appear suddenly while aura builds over minutes.
Treatment Considerations Specific to Migraine With Aura
Most acute migraine treatments work for both migraine with and without aura. However, some considerations are aura-specific.
Triptans during aura. Older guidance suggested taking triptans only after aura resolved (concern was vasoconstriction during a vasoconstricted phase). Current consensus, supported by AHS guidance, is that triptans can be taken during aura with no clear evidence of harm, though some clinicians still prefer waiting until headache begins4.
Vasoconstrictor avoidance. Severe cardiovascular disease can be a contraindication for triptans and ergotamines because of their vasoconstrictive effect. CGRP-targeted treatments (gepants like ubrogepant and rimegepant) don’t have vasoconstrictive effects and are often preferred for migraine with aura in patients with significant cardiovascular risk factors.
Preventive considerations. The standard migraine preventives (beta-blockers, topiramate, valproate, CGRP monoclonal antibodies) work for migraine with aura. Specific evidence for aura-only prevention is limited because most studies group migraine types.
Hormonal contraception. As above, combined hormonal contraceptives (estrogen-containing) are generally avoided in women with migraine with aura due to stroke risk. Progestin-only options, IUDs, and barrier methods are alternatives to discuss with a healthcare provider.
For the broader landscape of acute treatments and rescue strategies, see our guide to how to stop a migraine fast.
When to See a Neurologist
Most migraine with aura is well-managed in primary care or by a headache-trained provider. Several situations warrant neurology consultation or urgent evaluation:
- First-ever migraine with aura, especially after age 50 (must rule out other causes including stroke, TIA, intracranial mass)
- Aura lasting longer than 60 minutes (prolonged aura warrants imaging)
- Absence of subsequent headache when the aura pattern is new or changing
- Aura with motor weakness (hemiplegic migraine requires neurological care)
- Aura with brainstem symptoms (vertigo, double vision, slurred speech occurring together)
- Sudden severe headache described as “worst of life” or “thunderclap” (rule out subarachnoid hemorrhage)
- Change in aura pattern (new aura type, new location, new duration in someone with established migraine)
- Aura accompanied by fever, stiff neck, or other systemic symptoms
- Auras becoming more frequent or severe over time
- Failure to respond to standard acute migraine treatments
- Worsening of attacks despite preventive therapy
- Pregnancy planning or pregnancy with migraine with aura (medication safety review)
The general principle for migraine with aura: any change from the established pattern warrants evaluation. Migraine pattern stability is reassuring; change in pattern is the signal that other diagnoses must be considered.
Frequently Asked Questions
How can I tell migraine aura from a stroke?
Aura builds gradually over minutes; stroke symptoms appear suddenly. Aura typically resolves within the standard ICHD-3 aura duration; stroke symptoms persist1. Aura is often accompanied by a known migraine history; stroke is often a new neurological event. When in doubt, particularly for first-ever symptoms, treat as stroke until proven otherwise: call emergency services, get to a hospital, get imaging.
Can aura happen without a headache?
Yes. This is sometimes called “silent migraine” or “acephalgic migraine” and is more common in older adults. Each aura without headache should still match ICHD-3 criteria (gradual onset, fully reversible, characteristic timing) to fit the diagnosis. New-onset aura without headache after age 50 warrants neurology evaluation.
Does migraine with aura always start with vision changes?
Visual aura is the most common type but not the only type. Sensory aura, speech aura, motor aura, and brainstem aura can occur with or without visual symptoms. The defining feature is the aura itself, not specifically visual symptoms.
Will my aura get worse over time?
Not typically. Aura patterns tend to be stable in most individuals, with variations in frequency. Many people find aura becomes less prominent or disappears with age, while migraine headaches may persist. New types of aura developing later in life warrants medical evaluation.
Can I drive during an aura?
No, particularly with visual aura. Driving during visual disturbances is unsafe both for you and others. Pull over, wait until aura fully resolves, and then assess whether the headache phase has begun before deciding whether to continue driving. If headache is significant or you’ve taken medication that may impair driving, wait longer or find alternate transportation.
Sources
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. https://ichd-3.org/
- Kurth T, Diener HC. Migraine and stroke: perspectives for stroke physicians. Stroke. 2012;43(12):3421-3426. https://www.ahajournals.org/journal/str
- Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349.
- Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021-1039.